Phase 2 trial of palbociclib and ganitumab in patients with relapsed Ewing sarcoma.

David S ShulmanPriscilla MerriamEdwin ChoyLillian M GuentherKerri L CavanaughPei-Chi KaoAndrew PosnerKetki BhushanGrace FairchildEmma BarkerKelly KlegaKimberly StegmaierBrian D CromptonWendy B LondonSteven G DuBois

Published in: Cancer medicine (2023)

This combination lacks adequate therapeutic activity for further study, though a subset of patients had prolonged stable disease.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
prognostic factors
acute lymphoblastic leukemia
chronic kidney disease
acute myeloid leukemia
diffuse large b cell lymphoma
multiple myeloma
metastatic breast cancer
patient reported